LI-RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection

被引:4
作者
Zhang, Chunhui [1 ]
Yang, Rui [1 ]
Wang, Xinxin [2 ]
Tao, Yuqing [1 ]
Tang, Shuli [3 ]
Tian, Zhennan [4 ]
Zhou, Yang [2 ]
机构
[1] Harbin Med Univ Canc Hosp, Dept Gastrointestinal Med Oncol, Harbin, Heilongjiang, Peoples R China
[2] Harbin Med Univ Canc Hosp, Dept Radiol, Harbin, Heilongjiang, Peoples R China
[3] Harbin Med Univ Canc Hosp, Dept Outpatient Chemotherapy, Harbin, Heilongjiang, Peoples R China
[4] Harbin Med Univ Canc Hosp, Dept Pathol, Harbin, Heilongjiang, Peoples R China
关键词
Hepatocellular carcinoma; Magnetic resonance imaging; Morphological classification; Prediction; Prognosis; MACROSCOPIC CLASSIFICATION; INTRAHEPATIC RECURRENCE; RISK-FACTORS; PHASE;
D O I
10.1245/s10434-023-13494-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThis study aimed to explore the association of preoperative magnetic resonance imaging (MRI) tumor morphological classification with early recurrence (ER) and overall survival (OS) after radical surgery of hepatocellular carcinoma (HCC).Patients and MethodsA retrospective analysis of 296 patients with HCC who underwent radical resection was performed. On the basis of LI-RADS, tumor imaging morphology was classified into three types. The clinical imaging features, ER, and survival rates of three types were compared. Univariate and multivariate Cox regression analyses were conducted to identify prognostic factors associated with OS and ER after hepatectomy for HCC.ResultsThere were 167 tumors of type 1, 95 of type 2, and 34 of type 3. In patients with type 3 HCC, postoperative mortality and ER were significantly higher than in patients with type 1 and type 2 (55.9% versus 32.6% versus 27.5% and 52.9% versus 33.7% versus 28.7%). In multivariate analysis, the LI-RADS morphological type was a stronger risk factor for predicting poor OS [hazard ratio (HR) 2.77, 95% confidence interval (CI) 1.59-4.85, P < 0.001] and ER (HR 2.14, 95% CI 1.24-3.70, P = 0.007). A subgroup analysis revealed that type 3 was associated with poor OS and ER in > 5 cm cases but not in < 5 cm cases.ConclusionsER and OS of patients with HCC undergoing radical surgery can be predicted using the preoperative tumor LI-RADS morphological type, which could help to select personalized treatment plans for patients with HCC in the future.
引用
收藏
页码:4876 / 4885
页数:10
相关论文
共 50 条
  • [31] Optimizing diagnostic imaging data using LI-RADS and the Likert scale in patients with hepatocellular carcinoma
    Morad, Kholoud
    Moustafa, Amr F.
    Refaat, Amal M.
    AbdEllatif, Ahmed
    ElAzab, Mohammed S.
    [J]. POLISH JOURNAL OF RADIOLOGY, 2021, 86 : E557 - E563
  • [32] The significance of RDW in patients with hepatocellular carcinoma after radical resection
    Zhao, Teng
    Cui, Longjiu
    Li, Aijun
    [J]. CANCER BIOMARKERS, 2016, 16 (04) : 507 - 512
  • [33] A clinical-radiomic-pathomic model for prognosis prediction in patients with hepatocellular carcinoma after radical resection
    Xie, Qu
    Zhao, Zeyin
    Yang, Yanzhen
    Wang, Xiaohong
    Wu, Wei
    Jiang, Haitao
    Hao, Weiyuan
    Peng, Ruizi
    Luo, Cong
    [J]. CANCER MEDICINE, 2024, 13 (11):
  • [34] The nVR model: prediction of LI-RADS treatment response nonviable recurrence of hepatocellular carcinoma after primary transarterial chemoembolization
    Zhang, Shuhang
    Wang, Weilang
    Zhang, Xiuming
    Zhong, Binyan
    Feng, Feng
    Cai, Wu
    Li, Binrong
    Menon, Varsha Ajith
    Zhou, Shuwei
    Zhang, Teng
    Chen, Xunjun
    Ju, Shenghong
    Wang, Yuan-Cheng
    [J]. ABDOMINAL RADIOLOGY, 2025,
  • [35] Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals
    Vernuccio, Federica
    Cannella, Roberto
    Cabibbo, Giuseppe
    Greco, Silvia
    Celsa, Ciro
    Matteini, Francesco
    Giuffrida, Paolo
    Midiri, Massimo
    Di Marco, Vito
    Camma, Calogero
    Brancatelli, Giuseppe
    [J]. DIAGNOSTICS, 2022, 12 (05)
  • [36] Updates on LI-RADS Treatment Response Criteria for Hepatocellular Carcinoma: Focusing on MRI
    Patel, Richa
    Aslam, Anum
    Parikh, Neehar D.
    Mervak, Benjamin
    Mubarak, Eman
    Higgins, Lily
    Lala, Kayli
    Conner, Jack F.
    Khaykin, Valerie
    Bashir, Mustafa
    Do, Richard Kinh Gian
    Burke, Lauren M. B.
    Smith, Elainea N.
    Kim, Charles Y.
    Shampain, Kimberly L.
    Owen, Dawn
    Mendiratta-Lala, Mishal
    [J]. JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 57 (06) : 1641 - 1654
  • [37] LI-RADS for CT diagnosis of hepatocellular carcinoma: performance of major and ancillary features
    Ayman Alhasan
    Milena Cerny
    Damien Olivié
    Jean-Sébastien Billiard
    Catherine Bergeron
    Kip Brown
    Paule Bodson-Clermont
    Hélène Castel
    Simon Turcotte
    Pierre Perreault
    An Tang
    [J]. Abdominal Radiology, 2019, 44 : 517 - 528
  • [38] LI-RADS for CT diagnosis of hepatocellular carcinoma: performance of major and ancillary features
    Alhasan, Ayman
    Cerny, Milena
    Olivie, Damien
    Billiard, Jean-Sebastien
    Bergeron, Catherine
    Brown, Kip
    Bodson-Clermont, Paule
    Castel, Helene
    Turcotte, Simon
    Perreault, Pierre
    Tang, An
    [J]. ABDOMINAL RADIOLOGY, 2019, 44 (02) : 517 - 528
  • [39] Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm
    Ania Kielar
    Kathryn J. Fowler
    Sara Lewis
    Vahid Yaghmai
    Frank H. Miller
    Hooman Yarmohammadi
    Charles Kim
    Victoria Chernyak
    Takeshi Yokoo
    Jeffrey Meyer
    Isabel Newton
    Richard K. Do
    [J]. Abdominal Radiology, 2018, 43 : 218 - 230
  • [40] Evaluation of the LI-RADS treatment response algorithm in hepatocellular carcinoma after trans-arterial chemoembolization
    Kierans, Andrea S.
    Najjar, Marc
    Dutruel, Silvina P.
    Gavlin, Alexander
    Chen, Christine
    Lee, Michael J.
    Askin, Gulce
    Halazun, Karim J.
    [J]. CLINICAL IMAGING, 2021, 80 (80) : 117 - 122